首页> 中文期刊>癌症 >Analysis of the phosphatidylinosit ol 3'-kinase signaling pathway in glioblastoma patients in vivo

Analysis of the phosphatidylinosit ol 3'-kinase signaling pathway in glioblastoma patients in vivo

     

摘要

Deregulated signaling through the p hosphatidylinositol 3-kinase(PI3K)pathway is common in many types of can cer,including glioblastoma.Dissecting the molecular events associated with activation of this pathway in glioblastoma p atients in vivo presents an important challenge that has implic ations for the development and clini cal testing of PI3K pathway inhibito rs.Using an immunohistochemical analysis appl ied to a tissue microarray,we performed hierarchical clustering and mul tidimensional scaling,as well as univariate and multivariate analyses,to dissect the PI3K pathway in v ivo.We demonstrate that loss of the t umor suppressor protein PTEN,which antagonizes PI3K pathwa y activation,is highly correlated w ith activation of the main PI3K effec tor Akt in vivo.We also show that Akt activation is signific antly correlated with phosphorylation of mammalian target of rapamycin(mTOR),the family of forkhead transcription factors(FOXO1,FOXO3a,and FOXO4),and S6,which are thought to promote its effects.Expression of the mutan t epidermal growth factor receptor vIII is also tightly correlated with phosphorylation of these effectors,d emonstrating an additional route to PI3K pathway activation in glioblastomas in vivo.These results provide the first dissection of the PI3K path way in glioblastoma in vivo and suggest an approach to stratifying patients for targeted kinase inhi bitor

著录项

  • 来源
    《癌症》|2003年第7期|766-766|共1页
  • 作者单位

    Departments of Pathology and Labora tory Medicine,Departments of Pathology and Labora tory Medicine,Departments of Pathology and Labora tory Medicine,Departments of Pathology and Labora tory Medicine,Departments of Pathology and Labora tory Medicine,Departments of Pathology and Labora tory Medicine,Departments of Pathology and Labora tory Medicine,Departments of Pathology and Labora tory Medicine,Departments of Pathology and Labora tory Medicine,Departments of Pathology and Labora tory Medicine David Geffen School o f Medicine,University of Californi a Los Angeles,Los Angeles,California 90095,USA,David Geffen School o f Medicine,University of Californi a Los Angeles,Los Angeles,California 90095,USA,David Geffen School o f Medicine,University of Californi a Los Angeles,Los Angeles,California 90095,USA,David Geffen School o f Medicine,University of Californi a Los Angeles,Los Angeles,California 90095,USA,David Geffen School o f Medicine,University of Californi a Los Angeles,Los Angeles,California 90095,USA,David Geffen School o f Medicine,University of Californi a Los Angeles,Los Angeles,California 90095,USA,David Geffen School o f Medicine,University of Californi a Los Angeles,Los Angeles,California 90095,USA,David Geffen School o f Medicine,University of Californi a Los Angeles,Los Angeles,California 90095,USA,David Geffen School o f Medicine,University of Californi a Los Angeles,Los Angeles,California 90095,USA,David Geffen School o f Medicine,University of Californi a Los Angeles,Los Angeles,California 90095,USA;

  • 原文格式 PDF
  • 正文语种 chi
  • 中图分类 神经组织瘤;
  • 关键词

    神经胶质瘤; PI3K激酶; 信号通路; 免疫组织化学;

相似文献

  • 中文文献
  • 外文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号